Contact us


Prof. Dr. med. Heinz Wiendl (Münster)
University Hospital Muenster
Department of Neurology
Albert-Schweizer-Campus 1, Geb. A1, 48149 Münster
Tel: +49 251 83-46811
Fax: +49 251 83-46812
Email: heinz.wiendl@ukmuenster.de

 

 

Prof. Dr. Frauke ZippUniv-Prof. Dr. Frauke Zipp (rmn2)
University Medical Center of the Johannes-Gutenberg University, Mainz
Neurology Department
Langenbeckstr. 1
55131 Mainz
Tel.: +49 6131 17-7156
Email: frauke.zipp@unimedizin-mainz.de

 

 

Prof. Dr. med. Martin kerschensteiner (Munich)
Institute of Clinical Neuroimmunology
Ludwig Maximilians University, Munich
Marchioninistr. 15
81337 München
Tel.: +49 89 70954780
Fax: +49 89 70954781
Email: martin.kerschensteiner@med.uni-muenchen.de

 

 

Dr. rer. nat Annika Michaelis
University Hospital Muenster
Department of Neurology
Albert-Schweizer-Campus 1, Geb. A1
48149 Münster
Email: annikakathrin.michaelis@ukmuenster.de

 

News

Mon, 20/09/2021
Register now: 1st Symposium inflammation and imaging
When?: from November 2nd to November 4th 2021 Where?: Schloss (seat of the University Administration) Muenster Organizers: Co-operative Research Centres 1009, 1450, Transregio 128, and Clinical Research Unit 342 – together with Interdisciplinary Centre of Clinical Research (IZKF) and Excellence Cluster Cells in Motion (CiM) Registration is open now! More information: here...more
Mon, 09/08/2021
Dietary conjugated linoleic acid links reduced intestinal inflammation to amelioration of CNS autoimmunity
A close interaction between gut immune responses and distant organ-specific autoimmunity including the CNS in multiple sclerosis has been established in recent years. This so-called gut-CNS axis can be shaped by dietary factors, either directly or via indirect modulation of the gut microbiome and its metabolites. Here, SFB 128 PI Luisa Klotz and colleagues report […]...more
Thu, 28/01/2021
BioNTech Publishes Data on Novel mRNA Vaccine Approach to Treat Autoimmune Diseases in Science
BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) announced the publication of preclinical data on its novel mRNA vaccine approach against autoimmune diseases in the peer-reviewed journal Science. The publication titled “A non-inflammatory mRNA vaccine for treatment of experimental autoimmune encephalomyelitis” co-authored by SFB principal investigator Ari Waisman summarizes the findings on the disease-suppressing effects […]...more